Can Tonix Regain Its Former Glory With New Neurodegenerative Dysfunction Drug?
Tonix Pharma shares spiked on Friday after the firm announced that it received a patent from the European Patent Office for its “Method for Treating Neurodegenerative Dysfunction.”
















